Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination therapy in malignant disease.

M M Aloysius1, R A Robins, J M Eremin

  • 1Section of Surgery, Nottingham University Hospitals, Queen's Medical Centre, UK. mark.aloysius@nottingham.ac.uk

The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
|October 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decreased interferon-β induced STAT-4 activation in immune cells and clinical outcome in multiple sclerosis.

Acta neurologica Scandinavica·2016
Same author

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Acta physiologica (Oxford, England)·2015
Same author

T-cell subsets in tumour rejection responses.

Immunology today·2014
Same author

Review article: the endocannabinoid system in liver disease, a potential therapeutic target.

Alimentary pharmacology & therapeutics·2014
Same author

Expression of the intermediate affinity interleukin-2 receptor by a human solid tumor-cell line - evidence for functional-activity.

International journal of oncology·2011
Same author

Differential responses of human tumor-cells to polyunsaturated Fatty-acids - stimulation of proliferation of a colon-tumor cell-line by docosahexaenoic Acid.

International journal of oncology·2011

Anti-cancer immunotherapy shows promise for advanced cancers, offering a new strategy where traditional treatments fall short. This review explores the immune system

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Survival rates for early-stage cancers have improved, but advanced malignancy remains a significant clinical challenge.
  • Current therapeutic strategies for advanced cancers have limited impact on long-term survival.
  • Anti-cancer immunotherapy presents a novel and experimental therapeutic approach.

Purpose of the Study:

  • To review the fundamental immunological interactions between the host immune system and tumors.
  • To elucidate the mechanisms of anti-tumor immune responses stimulated by immunotherapy.
  • To summarize key in vivo pilot studies of active specific immunotherapy in solid cancers over the past five years.

Main Methods:

  • Literature review focusing on immunological interplay in cancer.

Related Experiment Videos

  • Analysis of mechanisms underlying immunotherapy-induced anti-tumor responses.
  • Synthesis of findings from recent in vivo pilot studies in solid tumors.

    • Main Results:

    • Discussion of the complex host immune system-tumor interactions.
    • Explanation of how immunotherapy elicits anti-tumor immune responses.
    • Presentation of data from recent immunotherapy pilot studies in various solid cancers.

    Conclusions:

    • Active specific immunotherapy offers a potential new therapeutic avenue for advanced malignancies.
    • Understanding the immune-tumor interplay is crucial for developing effective immunotherapies.
    • Recent pilot studies indicate the potential of immunotherapy in treating solid tumors.